Dipeptide Diaminobutyroyl Benzylamide Diacetate

CAT#

CPC1608

CAS No.

823202-99-9

Description

Dipeptide Diaminobutyroyl Benzylamide Diacetate, categorized as a neuro-peptide, is believed to block the body's uptake of Na+, which in turn causes the facial muscles to relax and prevent the formation of expression lines (wrinkles).

Synonyms/Alias

Syn-ake; Butanamide, UNII-38H206R00R

Molecular Formula

C19H29N5O3.2(C2H4O2)

M.W/Mr.

495.5733

Functions

Dipeptide Diaminobutyroyl Benzylamide Diacetate, as a safer alternative to botox, is mostly used in anti-aging products to inhibite muscle contractions and reduce wrinkles.

Technical Data

Background

Dipeptide diaminobutyroyl benzylamide diacetate is a tripeptide (a three amino acid peptide) with molecular weight less than 500 Da, meaning that it's small enough to penetrate nicely and easily into the skin.

References

Another peptide, unrelated to collagen synthesis and degradation, was formulated into the line treatment to target neuromuscular activity. Dipeptide diaminobutyroyl benzylamide diacetate was developed to mimic Waglerin-1, a compound found in temple viper snake venom. Waglerin-1 has been shown to block the nicotinic acetylcholine receptors at the neuromuscular junction, thus inhibiting muscular movement. The function of the Wagerlin-1-mimicking peptide is important for the treatment of lines since facial areas associated with repeated muscle movement are especially susceptible to wrinkle formation.